SBIR/STTR Research Award
I PARTS INTEGRATED PLATFORM FOR ANTI CANCER RADIATION THERAPEUTICS SCREENING
Award amount
$298,822Program and phase
SBIR · Phase IAward year
2017Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- PACT & HEALTH LLC
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- PYHDD9LBJ8B4
- Solicitation number
- Not reported
- Topic code
- NCI
Research abstract
We propose to develop an integrated module for high throughput clonogenic cell survival assay in cancer drug screening I PARTS Integrated platform for anti cancer radiation therapeutics screening combines the recent advances in cell culture automation microfluidics and high speed image analysis with the highthoughput X ray irradiation Commercially the product also has the scope and feasibility to analyze various cancer drugs with variable X ray doses and different cell lines in a high throughput manner Allowing the cells to grown in the dimensional environment with in vivo mimicking materials further facilitates the IPARTS module to be adopted in in patient tumor sample clonogenic survival assay predicting radiocurability Experimental validation and commercialization will be pursued by a phase II SBIR proposal
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- TOPIC 366: I-PARTS INTEGRATED PLATFORM FOR ANTI-CANCER RADIATION THERAPEUTICS SCREENING
- TOPIC 394 - A VERSATILE RADIATION-TRIGGERED PHOSPHOR PLATFORM FOR LOCALIZED ANTI-CANCER THERAPY
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Mini-reflectance confocal microscope (Mini-RCM) for aiding skin cancer diagnosis and treatment
- Development of small molecule therapeutics targeting AR-V7 for prostate cancer
- Decentralized Clinical Trial of Effectiveness of EnergyPoints App to Guide Acupressure Use for Fatigue and Sleep Disturbances in Cancer Survivors
- Optimized targeted radiotherapy of pancreatic cancer
- Adaptive imaging for pioneering multiplexed spatial profiling of tumors and tissues for cancer research and diagnosis
Research funding history
3 SBIR/STTR records share this UEI (2017–2019). Reported award amounts total $2,562,837. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services